Home Distributed Bio

Distributed Bio

acquired
-
Antibody and Vaccine Developer
Basic
Enterprise Profile

Basic Information

We are computational immunology engineers. Our mission is to create breakthrough technologies for previously challenging targets (GPCRs, ion channels, pMHC complexes, condition-specific binders, anti-idiotype, and broadly neutralizing viral epitopes) to deliver therapeutics. In monoclonal therapy, we integrate computational immunology, bioengineering, and robotics to enable the creation of molecular pipelines with unprecedented biophysical properties, while also providing all our partners with thousands of high-affinity developable antibodies against any drug target. In vaccine science, our Centivax technology is developing broad-spectrum vaccines for rapidly mutating pathogens such as influenza and HIV.
Distributed Bio, Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2010
info@distributedbio.com

Enterprise Profile

Industrial Sector
New Drug Development Vaccine Formulation Production
Technology
Machine Learning Immunological Techniques
Concept
Vaccination
Application Scenarios
Traditional Vaccines (Biological Products for Prevention)